Tim-3 pathway affects NK cell impairment in patients with active tuberculosis

被引:19
|
作者
Wang, Feng [1 ]
Hou, Hongyan [1 ]
Wu, Shiji [1 ]
Tang, Qing [1 ]
Huang, Min [1 ]
Yin, Botao [1 ]
Huang, Jing [1 ]
Liu, Weiyong [1 ]
Mao, Lie [1 ]
Lu, Yanfang [1 ]
Sun, Ziyong [1 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
Tim-3; NK cells; Tuberculosis; NATURAL-KILLER-CELLS; INTERFERON-GAMMA PRODUCTION; T-CELL; INNATE IMMUNITY; REGULATORY ROLE; GALECTIN-9; EXPRESSION; RECEPTOR; IMMUNOGLOBULIN; EXHAUSTION;
D O I
10.1016/j.cyto.2015.05.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Active tuberculosis (TB) patients show impaired NK cell function, and the underlying mechanism remains largely unknown. In this study, we confirmed the decrease in activation, cytokine secretion, and degranulation potential of NK cells in active TB patients. We further investigated whether coinhibitory receptor Tim-3 was involved with impairment of NK cells. Our results revealed that the expression of Tim-3 on NK cells was increased in active TB patients. Tim-3 expression was inversely correlated with IL-12-stimualted IFN-gamma production. Moreover, blocking the Tim-3 pathway restored IFN-gamma secretion and degranulation of NK cells. Blocking this pathway also increased NK cell cytotoxicity against K562 target cells, and improved the ability of NK cells to control Mtb growth in monocyte-derived macrophages. The Tim-3 expression on NK cells was also observed to be significantly decreased in TB patients post-treatment. In this study, we have identified that Tim-3 is involved with NK cell impairment in TB patients. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:270 / 279
页数:10
相关论文
共 50 条
  • [1] Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients
    Wang, Hui
    Cao, Kangli
    Liu, Siyu
    Xu, Yuanhong
    Tang, Ling
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
    Ahmady, Farah
    Curpen, Peter
    Perriman, Louis
    Teixeira, Adilson Fonseca
    Wu, Siqi
    Zhu, Hong-Jian
    Poddar, Arpita
    Jayachandran, Aparna
    Kannourakis, George
    Luwor, Rodney B.
    CELLS, 2024, 13 (21)
  • [3] Differential impact of TIM-3 ligands on NK cell function
    Wang, Juncheng
    Li, Housaiyin
    Kulkarni, Aditi
    Anderson, Jennifer L.
    Upadhyay, Pragati
    Onyekachi, Onyedikachi Victor
    Arantes, Lidia M. R. B.
    Banerjee, Hridesh
    Kane, Lawrence P.
    Zhang, Xin
    Bruno, Tullia C.
    Bao, Riyue
    Ferris, Robert L.
    Vujanovic, Lazar
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
  • [4] Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
    da Silva, Ines Pires
    Gallois, Anne
    Jimenez-Baranda, Sonia
    Khan, Shaukat
    Anderson, Ana C.
    Kuchroo, Vijay K.
    Osman, Iman
    Bhardwaj, Nina
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (05) : 410 - 422
  • [5] Tim-3 associated with apoptotic NK cells and disease activity in SLE
    Zhao, Di
    Yang, Xiao
    Zhang, Jie
    Zhang, Yi
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [6] The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer
    Wang, Zhenxin
    Zhu, Jinlian
    Gu, Haidi
    Yuan, Yuan
    Zhang, Bin
    Zhu, Dongming
    Zhou, Jian
    Zhu, Yibei
    Chen, Weichang
    IMMUNOLOGICAL INVESTIGATIONS, 2015, 44 (06) : 578 - 589
  • [7] NK cell expression of Tim-3: First impressions matter
    So, Edward C.
    Khaladj-Ghom, Ariana
    Ji, Yaping
    Amin, Julian
    Song, Yang
    Burch, Erin
    Zhou, Hua
    Sun, Haoping
    Chen, Shaodong
    Bentzen, Soren
    Hertzano, Ronna
    Zhang, Xiaoyu
    Strome, Scott E.
    IMMUNOBIOLOGY, 2019, 224 (03) : 362 - 370
  • [8] Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
    Xu, Liyun
    Huang, Yanyan
    Tan, Linlin
    Yu, Wei
    Chen, Dongdong
    Lu, ChangChang
    He, Jianying
    Wu, Guoqing
    Liu, Xiaoguang
    Zhang, Yongkui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 635 - 641
  • [9] The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy
    Li, Yan-Hong
    Zhou, Wen-Hui
    Tao, Yu
    Wang, Song-Cun
    Jiang, Yun-Lan
    Zhang, Di
    Piao, Hai-Lan
    Fu, Qiang
    Li, Da-Jin
    Du, Mei-Rong
    CELLULAR & MOLECULAR IMMUNOLOGY, 2016, 13 (01) : 73 - 81
  • [10] Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV plus patients
    Sada-Ovalle, Isabel
    Ocana-Guzman, Ranferi
    Perez-Patrigeon, Santiago
    Chavez-Galan, Leslie
    Sierra-Madero, Juan
    Torre-Bouscoulet, Luis
    Addo, Marylyn M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18